Skip to main content

Table 1 Patient baseline characteristics

From: Acute effects of combined exercise and oscillatory positive expiratory pressure therapy on sputum properties and lung diffusing capacity in cystic fibrosis: a randomized, controlled, crossover trial

Variables

N

16

Sex (male/female)

7/9

Age (years)

23 (22, 25)

BMI (kg m− 2)

20 (18, 21)

Cystic fibrosis-related diabetes (N (%))

8 (50)

Pancreatic insufficiency (N (%))

13 (81)

Chronic Pseudomonas aeruginosa infection (N (%))

7 (44)

FEV1 (% predicted)

52 (43, 72)

DLNO (% predicted)

59 (51, 73)

DLCO (% predicted)

82 (69, 86)

V’O2peak (mL kg− 1 min− 1)

32.0 (30.3, 34.4)

Mechanical power (W kg− 1)

2.9 (2.3, 3.1)

HRpeak (beats min− 1)

167 (163, 179)

RER

1.20 (1.15, 1.26)

  1. Data are median (IQR) or N (%). BMI body mass index, CF cystic fibrosis, DLCO diffusing capacity of the lung for carbon monoxide, DLNO diffusing capacity of the lung for nitric oxide, FEV 1 forced expiratory volume in one second, HR peak peak heart rate, RER respiratory exchange ratio, V’O 2peak peak oxygen consumption